Vincristine induced cranial polyneuropathy
Authors:
- 1 June 2006
- journal article
- case report
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 73 (6) , 531-533
Abstract
We describe a 5-year-old girl showed recovery of vincristine induced cranial polyneuropathy with pyridoxine and pyridostigmine treatment. A 5-year-old girl was diagnosed preB cell Acute Lymphoblastic Leukemia (ALL). She received chemotherapy according to the previously described modified St. Jude total therapy studies XIII. Five days after the fourth dose of vincristine, she presented with bilateral ptosis. Neurological examination revealed bilateral ptosis, and complete external opthalmoplegia with normal pupillary and corneal reflexes. She received 3.8 mg cumulative dose of vincristin before development of ptosis. A neuroprotective and neuroregenerative treatment attempt with pyridoxine and pyridostigmine was initiated. The bilateral ptosis markedly improved after 7 days of pyridoxine and pyridostigmine treatment and completely resolved after two weeks. The both agents were given for 3 weeks and were well tolerated without any side effects. During the follow up period we did not observe residue or recurrence of the ptosis.Keywords
This publication has 10 references indexed in Scilit:
- Treatment of vincristine‐induced bilateral ptosis with pyridoxine and pyridostigminePediatric Blood & Cancer, 2003
- Vincristine-Induced Neuropathy as the Initial Presentation of Charcot-Marie-Tooth Disease in Acute Lymphoblastic Leukemia: A Pediatric Oncology Group StudyJournal of Pediatric Hematology/Oncology, 2003
- Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-upLeukemia, 2003
- Chemotherapy-induced peripheral neuropathyJournal of Neurology, 2002
- Fulminant Peripheral Neuropathy with Severe Quadriparesis Associated with Vincristine TherapyAnnals of Pharmacotherapy, 2000
- Pharmacokinetic Drug Interactions of Vinca Alkaloids: Summary of Case ReportsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1998
- Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth diseaseMedical and Pediatric Oncology, 1996
- Vincristine NeurotoxicityMedical Toxicology, 1986
- Clinical trial of pyridoxine to reduce vincristine neurotoxicityJournal of Neuro-Oncology, 1986
- Colonic dysfunction in diabetes mellitusGastroenterology, 1980